Adaptimmune Therapeutics Plc American...

ADAP

5.24

+0.20

+4.0%

After Hours:

5.24

0.00

0.0%

Please Subscribe or Register

Login|Subscribe|Register

Stock Price
Open: 5.05
Prev. Close: 5.04
Low/Hi: 4.97 - 5.33
52-Week: 3.76 - 8.36
Volumes
Equity: 196,325
90-Day Avg: 217,704
Option: 10
90-Day Avg: 33
Volatility
Todays Stock Vol: 61.3
20-Day (HV): 64.9
52-Week (HV): 66.7
30-Day IV: 49.2 -1.4
IV Pct Rank: 5% Subdued
Fundamental
Div. Yield: 0.0%
Earnings: 10-Nov (Est.)
P/E Ratio:
Market Cap: 471.3 M
Stock Type: Common
ADR:
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common - ADR | Sector: Healthcare | Industry: Biotechnology

ADAP Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 121,998 170,559 158,779 140,440
Short Term Investments 80,023 0 0 0
Investments - - - -
Accounts Receivable 1,406 107 1,480 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 0 0 15,798 0
Net Property Plant and Equipment 38,922 35,092 27,899 15,086
Other Current Assets 34,317 52,266 22,694 59,104
Current Assets 237,744 222,932 198,751 199,544
Goodwill and Intangibles 1,431 1,310 1,268 1,127
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 284,279 265,980 234,515 222,644
Short Term Debt 0 0 0 0
Other Non-Current Assets 6,182 6,646 6,597 6,887
Accounts Payable 4,577 5,177 11,350 3,193
Accrued Liabilities and Other Payables 13,372 15,110 17,528 9,954
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 54,784 57,654 68,373 42,640
Other Current Liabilities 12,304 11,625 11,392 9,514
Accumulated Other Comprehensive Income -16,854 -14,366 -14,249 -13,788
Preferred Stock 0 0 0 0
Current Liabilities 30,253 31,912 40,270 22,661
Common Stock 853 801 683 682
Other Non-Current Liabilities 24,531 25,742 28,103 19,979
Additional Paid-In Capital 448,985 405,165 341,200 339,188
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -203,489 -183,274 -161,492 -146,078
Total Equity 229,495 208,326 166,142 180,004
Period Ending 31-Dec-2016
Cash and Cash Equivalents 158,779
Short Term Investments 0
Investments -
Accounts Receivable 1,480
Inventory 0
Loans -
Prepaid Expenses 15,798
Net Property Plant and Equipment 27,899
Other Current Assets 22,694
Current Assets 198,751
Goodwill and Intangibles 1,268
Long Term Investments 0
Other Assets -
Long Term Receivables 0
Total Assets 234,515
Short Term Debt 0
Other Non-Current Assets 6,597
Accounts Payable 11,350
Accrued Liabilities and Other Payables 17,528
Long Term Debt 0
Other Liabilities -
Current Portion of Long Term Debt 0
Total Liabilities 68,373
Other Current Liabilities 11,392
Accumulated Other Comprehensive Income -14,249
Preferred Stock 0
Current Liabilities 40,270
Common Stock 683
Other Non-Current Liabilities 28,103
Additional Paid-In Capital 341,200
Treasury Stock 0
Other Equity 0
Retained Earnings -161,492
Total Equity 166,142